Sharen schreef op 10 juli 2020 14:04:
[...]
Jaja, wensdenker' klopt, dat gaf ik al toe, is ook niets mis mee.
Maar je argumenten over 'waarom-niet-Sanofi' (zie vet hierboven) kloppen niet, lees maar:
finance.yahoo.com/news/acquiring-biom..."Sanofi CEO Paul Hudson told the Financial Times that the company wants to expand its pipeline "through our own R&D
and through acquisitions."
(dus niet alleen eigen pijplijn maar ook externe acquisities)
"An acquisition would be another step in Sanofi's plan to get out of heart and diabetes research and into cancer, immune diseases and uncommon blood disorders"
(dus niet alleen kanker, maar ook immuun- en bloedziektes )
"Sanofi SA has made it clear it wants to get into the rapidly growing gene therapy market"
(dus waar Pharming goed in is gebleken)